Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Hepatitis C virus linked to increased risk of developing Parkinson's disease

Hepatitis C virus linked to increased risk of developing Parkinson's disease

Scientists unravel longstanding mystery of fundamental property of the brain

Scientists unravel longstanding mystery of fundamental property of the brain

Researchers awarded $16 million NIH/NINDS grant to create methods for detecting CTE during life

Researchers awarded $16 million NIH/NINDS grant to create methods for detecting CTE during life

Researchers, patients trade new insights at International Dementia with Lewy Bodies Conference

Researchers, patients trade new insights at International Dementia with Lewy Bodies Conference

Researchers identify biochemical factors that may predict Alzheimer's disease

Researchers identify biochemical factors that may predict Alzheimer's disease

Bern study sheds light on the brain mechanism of arousal

Bern study sheds light on the brain mechanism of arousal

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Novel drug candidate prevents nerve cell damage in mouse model of Parkinson's disease

Novel drug candidate prevents nerve cell damage in mouse model of Parkinson's disease

New study sheds light on the molecular basis of memory and learning

New study sheds light on the molecular basis of memory and learning

Epilepsy deaths should be considered a public health priority, say doctors

Epilepsy deaths should be considered a public health priority, say doctors

Men perform wayfinding tasks better than women

Men perform wayfinding tasks better than women

Anemia associated with increased risk of mild cognitive impairment

Anemia associated with increased risk of mild cognitive impairment

CTE can be diagnosed by neuropathological examination of brain tissue

CTE can be diagnosed by neuropathological examination of brain tissue

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

Perceived stress increases likelihood of amnestic mild cognitive impairment in older people

Perceived stress increases likelihood of amnestic mild cognitive impairment in older people

New biobank initiative may help unlock some of the mysteries linked to Down syndrome

New biobank initiative may help unlock some of the mysteries linked to Down syndrome

Slow walking speed may herald Alzheimer’s disease

Slow walking speed may herald Alzheimer’s disease

Androgen deprivation therapy elevates Alzheimer’s risk

Androgen deprivation therapy elevates Alzheimer’s risk

Benefits of early dementia diagnosis may lead to challenging issues, new study shows

Benefits of early dementia diagnosis may lead to challenging issues, new study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.